Highly efficient yellow nondoped thermally activated delayed fluorescence OLEDs by utilizing energy transfer between dual conformations based on phenothiazine derivatives

Add time:07/22/2019    Source:sciencedirect.com

The nondoped thermally activated delayed fluorescence (TADF) devices are increasingly attracting attention due to the superior performances and simple fabrication process. By incorporating two acceptors with phenothiazine, two materials 2-(10H-phenothiazine-10-yl)-10-phenyl-10H-phenothiazine-5,5-dioxide (PTZ-2PTO) and 3-(10H-phenothiazin-10-yl)-10-phenylacridin-9(10H)-one (PTZ-AD) are designed and investigated. Both the two materials possess dual conformations, whereas the quasi-axial conformer is the main configuration of PTZ-2PTO and quasi-equatorial conformer of PTZ-AD is more stable. The quasi-axial conformers show classical fluorescence emission, and the quasi-equatorial conformers exhibit TADF characteristic. Fascinatingly more, efficient energy transfer can be achieved between quasi-axial conformers and quasi-equatorial conformers, exhibiting similar mechanism to the traditional host-guest system. Based on this characteristic, yellow nondoped TADF-OLED device of PTZ-AD has realized the efficiency of up to 17.08%, 50.48 cd A−1 and 60.04 lm W−1. Meanwhile, the PTZ-AD based nondoped device exhibits low turn-on voltage and low efficiency roll-off, which is among the best performance for yellow nondoped TADF devices. In addition, PTZ-AD based doped device realizes high efficiency of 20.23%, 61.04 cd A−1 and 68.45 lm W−1. This dual conformations forming host-guest system provides a new strategy for obtaining highly efficient nondoped OLEDs devices.

We also recommend Trading Suppliers and Manufacturers of 10H-phenothiazine 5,5-dioxide (cas 1209-66-1). Pls Click Website Link as below: cas 1209-66-1 suppliers

Prev:Infrared absorption, Raman, and SERS investigations in conjunction with theoretical simulations on a phenothiazine derivative
Next:Promoting effect of testosterone propionate on experimental exocrine pancreatic tumors by 4-hydroxyaminoquinoline 1-oxide in rats)